Viewing Study NCT00396812


Ignite Creation Date: 2025-12-26 @ 11:09 AM
Ignite Modification Date: 2026-02-02 @ 6:17 AM
Study NCT ID: NCT00396812
Status: TERMINATED
Last Update Posted: 2013-02-12
First Post: 2006-11-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Autoimmune disease View
None Biologic response modifiers View
None Disease-modifying antirheumatic drugs (DMARDS) View
None Immune system View
None Rheumatoid arthritis (RA) View
None Rituximab (anti-CD20 monoclonal antibodies) View